Loading clinical trials...
Loading clinical trials...
Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients: a Randomized, Parallel Controlled Clinical Trial
Conditions
Interventions
loxenatide Group
Gliclazide Group
Locations
1
China
Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University
Nanjing, Jiangsu, China
Start Date
May 10, 2020
Primary Completion Date
February 1, 2024
Completion Date
June 1, 2024
Last Updated
January 23, 2024
NCT07051005
NCT06887049
NCT07433062
NCT04943861
NCT07351786
NCT05099770
Lead Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions